| response to lipopolysaccharide | GO:0032496 | 128 | 0.695 | |
| interaction with symbiont | GO:0051702 | 14 | 0.695 | |
| cell killing | GO:0001906 | 67 | 0.587 | |
| negative regulation of multi organism process | GO:0043901 | 68 | 0.515 | |
| regulation of growth of symbiont in host | GO:0044126 | 19 | 0.506 | |
| interspecies interaction between organisms | GO:0044419 | 83 | 0.475 | |
| response to molecule of bacterial origin | GO:0002237 | 143 | 0.380 | |
| leukocyte migration | GO:0050900 | 124 | 0.353 | |
| defense response to other organism | GO:0098542 | 197 | 0.342 | |
| inflammatory response | GO:0006954 | 244 | 0.332 | |
| growth of symbiont in host | GO:0044117 | 23 | 0.330 | |
| symbiosis encompassing mutualism through parasitism | GO:0044403 | 83 | 0.319 | |
| regulation of symbiosis encompassing mutualism through parasitism | GO:0043903 | 52 | 0.313 | |
| positive regulation of defense response | GO:0031349 | 124 | 0.308 | |
| regulation of secretion | GO:0051046 | 274 | 0.307 | |
| killing of cells in other organism involved in symbiotic interaction | GO:0051883 | 13 | 0.300 | |
| immune effector process | GO:0002252 | 321 | 0.295 | |
| regulation of multi organism process | GO:0043900 | 111 | 0.290 | |
| disruption by host of symbiont cells | GO:0051852 | 11 | 0.278 | |
| cytokine production | GO:0001816 | 319 | 0.274 | |
| negative regulation of growth | GO:0045926 | 99 | 0.260 | |
| leukocyte mediated cytotoxicity | GO:0001909 | 62 | 0.242 | |
| modulation of growth of symbiont involved in interaction with host | GO:0044144 | 19 | 0.240 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.237 | |
| membrane organization | GO:0061024 | 245 | 0.226 | |
| negative regulation of growth of symbiont involved in interaction with host | GO:0044146 | 19 | 0.226 | |
| modification of morphology or physiology of other organism | GO:0035821 | 18 | 0.225 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.216 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.210 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.206 | |
| leukocyte migration involved in inflammatory response | GO:0002523 | 7 | 0.206 | |
| growth of symbiont involved in interaction with host | GO:0044116 | 23 | 0.203 | |
| regulation of defense response | GO:0031347 | 233 | 0.197 | |
| neutrophil mediated immunity | GO:0002446 | 19 | 0.193 | |
| regulation of inflammatory response | GO:0050727 | 147 | 0.189 | |
| killing by host of symbiont cells | GO:0051873 | 11 | 0.188 | |
| disruption of cells of other organism | GO:0044364 | 13 | 0.187 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.186 | |
| actin cytoskeleton organization | GO:0030036 | 220 | 0.172 | |
| adaptive immune response | GO:0002250 | 155 | 0.168 | |
| myeloid leukocyte migration | GO:0097529 | 57 | 0.167 | |
| innate immune response | GO:0045087 | 157 | 0.161 | |
| negative regulation of growth of symbiont in host | GO:0044130 | 19 | 0.158 | |
| disruption of cells of other organism involved in symbiotic interaction | GO:0051818 | 13 | 0.156 | |
| leukocyte aggregation | GO:0070486 | 1 | 0.156 | |
| innate immune response in mucosa | GO:0002227 | 3 | 0.148 | |
| regulation of cell motility | GO:2000145 | 236 | 0.143 | |
| adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002460 | 145 | 0.142 | |
| growth involved in symbiotic interaction | GO:0044110 | 23 | 0.139 | |
| chemotaxis | GO:0006935 | 247 | 0.139 | |
| positive regulation of response to wounding | GO:1903036 | 66 | 0.124 | |
| carboxylic acid biosynthetic process | GO:0046394 | 86 | 0.122 | |
| leukocyte activation involved in immune response | GO:0002366 | 126 | 0.121 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.119 | |
| defense response to bacterium | GO:0042742 | 119 | 0.118 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.118 | |
| amide transport | GO:0042886 | 138 | 0.117 | |
| ossification | GO:0001503 | 216 | 0.116 | |
| regulation of homeostatic process | GO:0032844 | 182 | 0.116 | |
| tissue remodeling | GO:0048771 | 102 | 0.116 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.112 | |
| eosinophil migration | GO:0072677 | 3 | 0.112 | |
| defense response to gram positive bacterium | GO:0050830 | 50 | 0.109 | |
| leukocyte mediated immunity | GO:0002443 | 174 | 0.108 | |
| lymphocyte differentiation | GO:0030098 | 242 | 0.104 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.103 | |
| acute inflammatory response | GO:0002526 | 41 | 0.103 | |
| protein citrullination | GO:0018101 | 2 | 0.101 | |
| circulatory system process | GO:0003013 | 197 | 0.101 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.101 | |
| muscle system process | GO:0003012 | 141 | 0.100 | |
| regulation of lymphocyte activation | GO:0051249 | 240 | 0.100 | |
| regulation of response to wounding | GO:1903034 | 189 | 0.099 | |
| leukocyte chemotaxis | GO:0030595 | 69 | 0.098 | |
| regulation of angiotensin metabolic process | GO:0060177 | 4 | 0.098 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.097 | |
| response to zinc ion | GO:0010043 | 5 | 0.096 | |
| response to oxygen radical | GO:0000305 | 16 | 0.096 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.095 | |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.094 | |
| myeloid leukocyte mediated immunity | GO:0002444 | 42 | 0.093 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.092 | |
| cell activation involved in immune response | GO:0002263 | 126 | 0.089 | |
| positive regulation of inflammatory response | GO:0050729 | 47 | 0.089 | |
| modification of morphology or physiology of other organism involved in symbiotic interaction | GO:0051817 | 16 | 0.089 | |
| cell recognition | GO:0008037 | 83 | 0.089 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.087 | |
| blood circulation | GO:0008015 | 195 | 0.087 | |
| cytokine mediated signaling pathway | GO:0019221 | 115 | 0.085 | |
| bone remodeling | GO:0046849 | 53 | 0.085 | |
| forebrain development | GO:0030900 | 302 | 0.085 | |
| muscle contraction | GO:0006936 | 101 | 0.084 | |
| heart morphogenesis | GO:0003007 | 178 | 0.083 | |
| cellular response to acid chemical | GO:0071229 | 68 | 0.082 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.082 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.081 | |
| rho protein signal transduction | GO:0007266 | 32 | 0.081 | |
| regulation of muscle system process | GO:0090257 | 80 | 0.080 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 194 | 0.080 | |
| regulation of actin filament based process | GO:0032970 | 99 | 0.079 | |
| leukocyte cell cell adhesion | GO:0007159 | 14 | 0.079 | |
| urogenital system development | GO:0001655 | 261 | 0.079 | |
| lymphocyte mediated immunity | GO:0002449 | 139 | 0.077 | |
| muscle tissue development | GO:0060537 | 308 | 0.077 | |
| response to light stimulus | GO:0009416 | 135 | 0.076 | |
| locomotory behavior | GO:0007626 | 195 | 0.075 | |
| positive regulation of cell migration | GO:0030335 | 109 | 0.075 | |
| regulation of body fluid levels | GO:0050878 | 162 | 0.075 | |
| anatomical structure homeostasis | GO:0060249 | 145 | 0.075 | |
| interleukin 8 production | GO:0032637 | 4 | 0.074 | |
| homeostasis of number of cells | GO:0048872 | 210 | 0.073 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.072 | |
| bone resorption | GO:0045453 | 38 | 0.072 | |
| killing of cells of other organism | GO:0031640 | 13 | 0.072 | |
| skeletal system development | GO:0001501 | 356 | 0.071 | |
| positive regulation of peptidase activity | GO:0010952 | 49 | 0.069 | |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.068 | |
| response to inorganic substance | GO:0010035 | 96 | 0.068 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.067 | |
| response to acid chemical | GO:0001101 | 111 | 0.067 | |
| neutrophil mediated killing of fungus | GO:0070947 | 3 | 0.067 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.067 | |
| fat cell differentiation | GO:0045444 | 160 | 0.067 | |
| oocyte axis specification | GO:0007309 | 2 | 0.066 | |
| multicellular organismal homeostasis | GO:0048871 | 164 | 0.065 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.065 | |
| regulation of cell activation | GO:0050865 | 289 | 0.064 | |
| alpha beta t cell differentiation | GO:0046632 | 69 | 0.063 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.063 | |
| positive regulation of cell motility | GO:2000147 | 116 | 0.063 | |
| regulation of interleukin 8 production | GO:0032677 | 3 | 0.062 | |
| small molecule biosynthetic process | GO:0044283 | 132 | 0.062 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.061 | |
| amine metabolic process | GO:0009308 | 45 | 0.061 | |
| response to radiation | GO:0009314 | 165 | 0.061 | |
| single organism cell adhesion | GO:0098602 | 156 | 0.061 | |
| cellular homeostasis | GO:0019725 | 240 | 0.061 | |
| cellular response to monosaccharide stimulus | GO:0071326 | 47 | 0.060 | |
| regulation of vesicle mediated transport | GO:0060627 | 139 | 0.060 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.060 | |
| cell chemotaxis | GO:0060326 | 81 | 0.059 | |
| cellular response to lipid | GO:0071396 | 145 | 0.059 | |
| t cell activation | GO:0042110 | 289 | 0.058 | |
| reactive oxygen species metabolic process | GO:0072593 | 84 | 0.058 | |
| regulation of angiotensin levels in blood | GO:0002002 | 4 | 0.057 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.057 | |
| regulation of ras protein signal transduction | GO:0046578 | 114 | 0.056 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.056 | |
| cell adhesion | GO:0007155 | 329 | 0.056 | |
| positive regulation of cellular catabolic process | GO:0031331 | 148 | 0.055 | |
| myeloid leukocyte differentiation | GO:0002573 | 119 | 0.055 | |
| regulation of endocytosis | GO:0030100 | 69 | 0.055 | |
| membrane depolarization | GO:0051899 | 64 | 0.054 | |
| chromatin organization | GO:0006325 | 206 | 0.054 | |
| positive regulation of proteolysis | GO:0045862 | 85 | 0.054 | |
| cellular response to glucose stimulus | GO:0071333 | 45 | 0.053 | |
| regulation of renin secretion into blood stream | GO:1900133 | 4 | 0.053 | |
| defense response to nematode | GO:0002215 | 4 | 0.052 | |
| epidermis development | GO:0008544 | 187 | 0.052 | |
| appendage morphogenesis | GO:0035107 | 149 | 0.051 | |
| bone development | GO:0060348 | 120 | 0.051 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.050 | |
| amino sugar catabolic process | GO:0046348 | 1 | 0.050 | |
| regulation of engulfment of apoptotic cell | GO:1901074 | 2 | 0.050 | |
| regulation of map kinase activity | GO:0043405 | 120 | 0.050 | |
| stem cell differentiation | GO:0048863 | 268 | 0.050 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.049 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.049 | |
| alpha amino acid biosynthetic process | GO:1901607 | 15 | 0.049 | |
| cell junction organization | GO:0034330 | 77 | 0.049 | |
| respiratory burst | GO:0045730 | 8 | 0.049 | |
| homotypic cell cell adhesion | GO:0034109 | 28 | 0.049 | |
| cellular modified amino acid biosynthetic process | GO:0042398 | 12 | 0.049 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.048 | |
| oocyte construction | GO:0007308 | 2 | 0.048 | |
| organelle localization | GO:0051640 | 179 | 0.048 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.048 | |
| lipoxin a4 biosynthetic process | GO:2001303 | 1 | 0.047 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.047 | |
| oxidation reduction process | GO:0055114 | 342 | 0.047 | |
| positive regulation of transferase activity | GO:0051347 | 167 | 0.047 | |
| neutrophil mediated killing of gram positive bacterium | GO:0070946 | 2 | 0.047 | |
| extracellular structure organization | GO:0043062 | 148 | 0.046 | |
| activation of mapk activity | GO:0000187 | 59 | 0.046 | |
| regulation of peptide transport | GO:0090087 | 91 | 0.045 | |
| activation of cysteine type endopeptidase activity | GO:0097202 | 27 | 0.045 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.045 | |
| actin filament organization | GO:0007015 | 113 | 0.045 | |
| cellular ion homeostasis | GO:0006873 | 165 | 0.045 | |
| cellular response to carbohydrate stimulus | GO:0071322 | 50 | 0.045 | |
| cellular response to biotic stimulus | GO:0071216 | 92 | 0.044 | |
| gland development | GO:0048732 | 330 | 0.044 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.044 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.044 | |
| positive regulation of nucleotide metabolic process | GO:0045981 | 114 | 0.044 | |
| positive regulation of lymphocyte proliferation | GO:0050671 | 70 | 0.043 | |
| positive regulation of cysteine type endopeptidase activity involved in apoptotic process | GO:0043280 | 36 | 0.043 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.042 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.042 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.042 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.042 | |
| positive regulation of lymphocyte activation | GO:0051251 | 140 | 0.042 | |
| positive regulation of innate immune response | GO:0045089 | 80 | 0.042 | |
| cell maturation | GO:0048469 | 127 | 0.042 | |
| embryonic placenta development | GO:0001892 | 98 | 0.041 | |
| regulation of chemokine production | GO:0032642 | 30 | 0.041 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.041 | |
| regulation of systemic arterial blood pressure | GO:0003073 | 61 | 0.041 | |
| exocrine system development | GO:0035272 | 45 | 0.040 | |
| positive regulation of adaptive immune response | GO:0002821 | 61 | 0.040 | |
| action potential | GO:0001508 | 78 | 0.040 | |
| signal transduction in absence of ligand | GO:0038034 | 55 | 0.040 | |
| sensory perception of pain | GO:0019233 | 47 | 0.040 | |
| cellular response to extracellular stimulus | GO:0031668 | 81 | 0.040 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.039 | |
| anion transport | GO:0006820 | 177 | 0.039 | |
| negative regulation of lipopolysaccharide mediated signaling pathway | GO:0031665 | 3 | 0.039 | |
| regulation of ossification | GO:0030278 | 112 | 0.039 | |
| regulation of bone remodeling | GO:0046850 | 28 | 0.039 | |
| extrinsic apoptotic signaling pathway | GO:0097191 | 126 | 0.039 | |
| establishment of organelle localization | GO:0051656 | 122 | 0.039 | |
| cellular response to oxygen radical | GO:0071450 | 14 | 0.039 | |
| chromatin modification | GO:0016568 | 187 | 0.039 | |
| regulation of protein localization | GO:0032880 | 231 | 0.039 | |
| regulation of protein serine threonine kinase activity | GO:0071900 | 157 | 0.038 | |
| axonogenesis | GO:0007409 | 274 | 0.038 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.038 | |
| engulfment of apoptotic cell | GO:0043652 | 3 | 0.038 | |
| developmental growth involved in morphogenesis | GO:0060560 | 138 | 0.038 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.038 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.038 | |
| regulation of innate immune response | GO:0045088 | 91 | 0.038 | |
| microtubule based process | GO:0007017 | 236 | 0.038 | |
| glucose homeostasis | GO:0042593 | 128 | 0.038 | |
| cation transmembrane transport | GO:0098655 | 266 | 0.038 | |
| response to monosaccharide | GO:0034284 | 67 | 0.037 | |
| carbohydrate homeostasis | GO:0033500 | 128 | 0.037 | |
| response to oxidative stress | GO:0006979 | 123 | 0.037 | |
| maintenance of location | GO:0051235 | 89 | 0.037 | |
| phospholipid metabolic process | GO:0006644 | 87 | 0.037 | |
| antibacterial humoral response | GO:0019731 | 8 | 0.037 | |
| organic acid biosynthetic process | GO:0016053 | 86 | 0.037 | |
| kidney epithelium development | GO:0072073 | 121 | 0.037 | |
| neutrophil migration | GO:1990266 | 37 | 0.037 | |
| cation transport | GO:0006812 | 399 | 0.037 | |
| negative regulation of cytokine production | GO:0001818 | 84 | 0.036 | |
| tissue homeostasis | GO:0001894 | 115 | 0.036 | |
| multicellular organism growth | GO:0035264 | 161 | 0.036 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.036 | |
| peptide secretion | GO:0002790 | 114 | 0.036 | |
| transmembrane transport | GO:0055085 | 412 | 0.036 | |
| organelle assembly | GO:0070925 | 177 | 0.036 | |
| lymphocyte proliferation | GO:0046651 | 164 | 0.036 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.036 | |
| regulation of proteolysis | GO:0030162 | 164 | 0.036 | |
| positive regulation of protein serine threonine kinase activity | GO:0071902 | 106 | 0.036 | |
| renal system development | GO:0072001 | 225 | 0.035 | |
| positive regulation of protein kinase activity | GO:0045860 | 144 | 0.035 | |
| neuron death | GO:0070997 | 154 | 0.035 | |
| endocytosis | GO:0006897 | 168 | 0.035 | |
| synaptic transmission | GO:0007268 | 329 | 0.035 | |
| positive regulation of cytokine production | GO:0001819 | 174 | 0.035 | |
| camera type eye development | GO:0043010 | 266 | 0.035 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.034 | |
| cell growth | GO:0016049 | 130 | 0.034 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.034 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.034 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.034 | |
| arachidonic acid metabolite production involved in inflammatory response | GO:0002538 | 2 | 0.034 | |
| positive regulation of intracellular transport | GO:0032388 | 70 | 0.034 | |
| extracellular matrix organization | GO:0030198 | 147 | 0.034 | |
| regulation of synaptic plasticity | GO:0048167 | 87 | 0.034 | |
| superoxide metabolic process | GO:0006801 | 27 | 0.034 | |
| regulation of epithelial cell proliferation | GO:0050678 | 141 | 0.033 | |
| regulation of actin cytoskeleton organization | GO:0032956 | 84 | 0.033 | |
| cerebral cortex development | GO:0021987 | 86 | 0.033 | |
| gtp catabolic process | GO:0006184 | 143 | 0.033 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.033 | |
| skeletal system morphogenesis | GO:0048705 | 203 | 0.033 | |
| protein catabolic process | GO:0030163 | 221 | 0.033 | |
| dna metabolic process | GO:0006259 | 303 | 0.033 | |
| monocarboxylic acid metabolic process | GO:0032787 | 191 | 0.033 | |
| response to extracellular stimulus | GO:0009991 | 127 | 0.033 | |
| regulation of cytoskeleton organization | GO:0051493 | 122 | 0.033 | |
| l amino acid transport | GO:0015807 | 32 | 0.033 | |
| peptide transport | GO:0015833 | 133 | 0.032 | |
| negative regulation of apoptotic signaling pathway | GO:2001234 | 104 | 0.032 | |
| positive regulation of apoptotic signaling pathway | GO:2001235 | 95 | 0.032 | |
| neutrophil mediated cytotoxicity | GO:0070942 | 8 | 0.032 | |
| granulocyte migration | GO:0097530 | 43 | 0.032 | |
| removal of superoxide radicals | GO:0019430 | 12 | 0.032 | |
| regulation of endopeptidase activity | GO:0052548 | 89 | 0.032 | |
| organic hydroxy compound transport | GO:0015850 | 93 | 0.032 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.031 | |
| protein maturation | GO:0051604 | 176 | 0.031 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.031 | |
| cellular glucose homeostasis | GO:0001678 | 52 | 0.030 | |
| positive regulation of endopeptidase activity | GO:0010950 | 43 | 0.030 | |
| response to reactive oxygen species | GO:0000302 | 56 | 0.030 | |
| positive regulation of hydrolase activity | GO:0051345 | 148 | 0.030 | |
| cellular response to external stimulus | GO:0071496 | 88 | 0.030 | |
| lipoprotein metabolic process | GO:0042157 | 43 | 0.029 | |
| intracellular mrna localization | GO:0008298 | 4 | 0.029 | |
| striated muscle contraction | GO:0006941 | 45 | 0.029 | |
| positive regulation of toll like receptor 4 signaling pathway | GO:0034145 | 1 | 0.029 | |
| negative regulation of ossification | GO:0030279 | 49 | 0.029 | |
| regulation of rho protein signal transduction | GO:0035023 | 71 | 0.029 | |
| single organismal cell cell adhesion | GO:0016337 | 131 | 0.029 | |
| negative regulation of interleukin 8 production | GO:0032717 | 1 | 0.029 | |
| regulation of tissue remodeling | GO:0034103 | 38 | 0.028 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.028 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.028 | |
| wnt signaling pathway | GO:0016055 | 188 | 0.028 | |
| developmental cell growth | GO:0048588 | 84 | 0.028 | |
| organophosphate biosynthetic process | GO:0090407 | 122 | 0.028 | |
| regulation of integrin biosynthetic process | GO:0045113 | 1 | 0.028 | |
| cellular response to cytokine stimulus | GO:0071345 | 189 | 0.028 | |
| regulation of leukocyte apoptotic process | GO:2000106 | 56 | 0.028 | |
| regulation of peptide secretion | GO:0002791 | 77 | 0.028 | |
| formation of radial glial scaffolds | GO:0021943 | 4 | 0.028 | |
| ion transmembrane transport | GO:0034220 | 361 | 0.027 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.027 | |
| t cell proliferation | GO:0042098 | 120 | 0.027 | |
| mesangial cell differentiation | GO:0072007 | 4 | 0.027 | |
| pole plasm assembly | GO:0007315 | 2 | 0.027 | |
| erythrocyte differentiation | GO:0030218 | 88 | 0.027 | |
| cellular response to transforming growth factor beta stimulus | GO:0071560 | 88 | 0.027 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.027 | |
| cation homeostasis | GO:0055080 | 212 | 0.027 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.027 | |
| telencephalon development | GO:0021537 | 186 | 0.026 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.026 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.026 | |
| modification by host of symbiont morphology or physiology | GO:0051851 | 12 | 0.026 | |
| regulation of protein binding | GO:0043393 | 60 | 0.026 | |
| g protein coupled receptor signaling pathway | GO:0007186 | 243 | 0.026 | |
| positive regulation of homeostatic process | GO:0032846 | 64 | 0.026 | |
| regulation of cysteine type endopeptidase activity | GO:2000116 | 65 | 0.026 | |
| intrinsic apoptotic signaling pathway | GO:0097193 | 132 | 0.026 | |
| positive regulation of organelle organization | GO:0010638 | 128 | 0.026 | |
| integrin biosynthetic process | GO:0045112 | 1 | 0.026 | |
| microtubule cytoskeleton organization | GO:0000226 | 157 | 0.026 | |
| granulocyte chemotaxis | GO:0071621 | 39 | 0.026 | |
| fatty acid derivative biosynthetic process | GO:1901570 | 15 | 0.025 | |
| purine nucleotide catabolic process | GO:0006195 | 211 | 0.025 | |
| positive regulation of mapk cascade | GO:0043410 | 170 | 0.025 | |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.025 | |
| regulation of bone resorption | GO:0045124 | 24 | 0.025 | |
| morphogenesis of a branching structure | GO:0001763 | 203 | 0.025 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.025 | |
| endomembrane system organization | GO:0010256 | 147 | 0.025 | |
| mapk cascade | GO:0000165 | 281 | 0.025 | |
| cardiac chamber morphogenesis | GO:0003206 | 93 | 0.025 | |
| hemangioblast cell differentiation | GO:0060217 | 1 | 0.025 | |
| sensory perception | GO:0007600 | 245 | 0.025 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.025 | |
| hemostasis | GO:0007599 | 78 | 0.025 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.025 | |
| regulation of blood circulation | GO:1903522 | 93 | 0.025 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.025 | |
| negative regulation of cell activation | GO:0050866 | 111 | 0.025 | |
| digestive tract morphogenesis | GO:0048546 | 147 | 0.025 | |
| skeletal muscle organ development | GO:0060538 | 163 | 0.025 | |
| neuron migration | GO:0001764 | 122 | 0.025 | |
| mucosal immune response | GO:0002385 | 13 | 0.025 | |
| covalent chromatin modification | GO:0016569 | 163 | 0.025 | |
| cellular response to oxidative stress | GO:0034599 | 76 | 0.025 | |
| branching morphogenesis of an epithelial tube | GO:0048754 | 159 | 0.024 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.024 | |
| cellular response to superoxide | GO:0071451 | 14 | 0.024 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 167 | 0.024 | |
| regulation of adaptive immune response | GO:0002819 | 90 | 0.024 | |
| phospholipase c activating g protein coupled receptor signaling pathway | GO:0007200 | 26 | 0.024 | |
| regulation of wound healing | GO:0061041 | 40 | 0.024 | |
| exocytosis | GO:0006887 | 121 | 0.024 | |
| regulation of exocytosis | GO:0017157 | 61 | 0.024 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.024 | |
| lymphocyte activation involved in immune response | GO:0002285 | 93 | 0.024 | |
| leukocyte proliferation | GO:0070661 | 172 | 0.024 | |
| skin development | GO:0043588 | 220 | 0.024 | |
| stem cell development | GO:0048864 | 219 | 0.024 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.024 | |
| histone modification | GO:0016570 | 159 | 0.024 | |
| regulation of interleukin 8 secretion | GO:2000482 | 2 | 0.024 | |
| defense response to fungus | GO:0050832 | 12 | 0.024 | |
| adult behavior | GO:0030534 | 135 | 0.024 | |
| regulation of vasculature development | GO:1901342 | 88 | 0.024 | |
| positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002824 | 61 | 0.024 | |
| negative regulation of phagocytosis | GO:0050765 | 4 | 0.024 | |
| mitochondrion organization | GO:0007005 | 134 | 0.024 | |
| regulation of cellular component size | GO:0032535 | 121 | 0.024 | |
| innate immune response activating signal transduction | GO:0002758 | 50 | 0.024 | |
| glomerular mesangial cell development | GO:0072144 | 3 | 0.023 | |
| positive regulation of chemotaxis | GO:0050921 | 38 | 0.023 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.023 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.023 | |
| regulation of protein transport | GO:0051223 | 163 | 0.023 | |
| fatty acid biosynthetic process | GO:0006633 | 41 | 0.023 | |
| ear morphogenesis | GO:0042471 | 118 | 0.023 | |
| positive regulation of cysteine type endopeptidase activity | GO:2001056 | 39 | 0.023 | |
| cellular macromolecule catabolic process | GO:0044265 | 206 | 0.023 | |
| negative regulation of interleukin 5 production | GO:0032714 | 4 | 0.023 | |
| positive regulation of synaptic plasticity | GO:0031915 | 4 | 0.023 | |
| endochondral bone morphogenesis | GO:0060350 | 50 | 0.023 | |
| neutrophil chemotaxis | GO:0030593 | 36 | 0.023 | |
| angiogenesis | GO:0001525 | 201 | 0.023 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.023 | |
| regulation of neuron projection development | GO:0010975 | 169 | 0.022 | |
| activation of cysteine type endopeptidase activity involved in apoptotic process | GO:0006919 | 27 | 0.022 | |
| digestive tract development | GO:0048565 | 190 | 0.022 | |
| establishment of endothelial blood brain barrier | GO:0014045 | 3 | 0.022 | |
| oocyte anterior posterior axis specification | GO:0007314 | 2 | 0.022 | |
| phosphatidylethanolamine biosynthetic process | GO:0006646 | 2 | 0.022 | |
| epithelial cell development | GO:0002064 | 159 | 0.022 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.022 | |
| receptor mediated endocytosis | GO:0006898 | 51 | 0.022 | |
| citrulline metabolic process | GO:0000052 | 3 | 0.022 | |
| positive regulation of t cell receptor signaling pathway | GO:0050862 | 4 | 0.022 | |
| metal ion homeostasis | GO:0055065 | 189 | 0.022 | |
| negative regulation of cellular amino acid metabolic process | GO:0045763 | 0 | 0.022 | |
| axonal fasciculation | GO:0007413 | 15 | 0.022 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.022 | |
| digestive system development | GO:0055123 | 200 | 0.021 | |
| positive regulation of interleukin 8 production | GO:0032757 | 2 | 0.021 | |
| insulin secretion | GO:0030073 | 89 | 0.021 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 199 | 0.021 | |
| dendrite development | GO:0016358 | 115 | 0.021 | |
| response to alcohol | GO:0097305 | 48 | 0.021 | |
| granzyme mediated apoptotic signaling pathway | GO:0008626 | 1 | 0.021 | |
| regulation of protein catabolic process | GO:0042176 | 108 | 0.021 | |
| divalent inorganic cation homeostasis | GO:0072507 | 138 | 0.021 | |
| memory | GO:0007613 | 58 | 0.021 | |
| protein processing | GO:0016485 | 163 | 0.021 | |
| bone mineralization | GO:0030282 | 54 | 0.021 | |
| regulation of cell migration | GO:0030334 | 219 | 0.021 | |
| positive regulation of secretion | GO:0051047 | 130 | 0.021 | |
| cellular response to lipopolysaccharide | GO:0071222 | 77 | 0.021 | |
| regulation of neuron death | GO:1901214 | 134 | 0.021 | |
| regulation of intrinsic apoptotic signaling pathway | GO:2001242 | 61 | 0.021 | |
| negative regulation of cell development | GO:0010721 | 169 | 0.021 | |
| cellular response to nutrient levels | GO:0031669 | 64 | 0.021 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.021 | |
| monoamine transport | GO:0015844 | 33 | 0.020 | |
| regulation of homotypic cell cell adhesion | GO:0034110 | 13 | 0.020 | |
| regulation of protein secretion | GO:0050708 | 82 | 0.020 | |
| microglia differentiation | GO:0014004 | 2 | 0.020 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.020 | |
| labyrinthine layer development | GO:0060711 | 49 | 0.020 | |
| positive regulation of cell adhesion | GO:0045785 | 80 | 0.020 | |
| response to growth factor | GO:0070848 | 198 | 0.020 | |
| inorganic cation transmembrane transport | GO:0098662 | 207 | 0.020 | |
| reactive oxygen species biosynthetic process | GO:1903409 | 8 | 0.020 | |
| wound healing | GO:0042060 | 157 | 0.020 | |
| actin filament bundle assembly | GO:0051017 | 40 | 0.020 | |
| hindbrain development | GO:0030902 | 128 | 0.020 | |
| neutrophil mediated killing of symbiont cell | GO:0070943 | 8 | 0.020 | |
| regulation of excitatory postsynaptic membrane potential | GO:0060079 | 41 | 0.020 | |
| natural killer cell activation | GO:0030101 | 44 | 0.020 | |
| negative regulation of cellular amine metabolic process | GO:0033239 | 1 | 0.020 | |
| negative regulation of nervous system development | GO:0051961 | 156 | 0.020 | |
| morphogenesis of embryonic epithelium | GO:0016331 | 159 | 0.020 | |
| zymogen activation | GO:0031638 | 41 | 0.020 | |
| mature dendritic cell differentiation | GO:0097029 | 3 | 0.020 | |
| regulation of osteoblast differentiation | GO:0045667 | 67 | 0.020 | |
| kidney development | GO:0001822 | 213 | 0.019 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.019 | |
| neurotransmitter transport | GO:0006836 | 76 | 0.019 | |
| central nervous system neuron differentiation | GO:0021953 | 162 | 0.019 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.019 | |
| regulation of lymphocyte mediated immunity | GO:0002706 | 84 | 0.019 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.019 | |
| plasma membrane organization | GO:0007009 | 90 | 0.019 | |
| response to nutrient levels | GO:0031667 | 109 | 0.019 | |
| myeloid cell homeostasis | GO:0002262 | 114 | 0.019 | |
| positive regulation of bone remodeling | GO:0046852 | 13 | 0.019 | |
| regulation of system process | GO:0044057 | 200 | 0.019 | |
| reactive nitrogen species metabolic process | GO:2001057 | 0 | 0.019 | |
| positive regulation of cytokine secretion | GO:0050715 | 41 | 0.019 | |
| striated muscle cell development | GO:0055002 | 125 | 0.019 | |
| protein localization to organelle | GO:0033365 | 185 | 0.019 | |
| regulation of synaptic growth at neuromuscular junction | GO:0008582 | 4 | 0.019 | |
| positive regulation of ras protein signal transduction | GO:0046579 | 13 | 0.019 | |
| pallium development | GO:0021543 | 120 | 0.019 | |
| regulation of toll like receptor 4 signaling pathway | GO:0034143 | 4 | 0.019 | |
